OC-0268 Should OARs be prioritized in SABR for oligometastases? A secondary analysis of the SABR-5 trial

Autor: Cereno, R.E., Mou, B., Baker, S., Chng, N., Arbour, G., Bergman, A., Liu, M., Schellenberg, D., Matthews, Q., Huang, V., Mestrovic, A., Hyde, D., Alexander, A., Carolan, H., Hsu, F., Atrchian, S., Mohamed, I., Lin, A., Berrang, T., Bang, A., Jiang, W., Pai, H., Tyldesley, S., Olson, R.
Zdroj: In Radiotherapy and Oncology May 2023 182 Supplement 1:S204-S205
Databáze: ScienceDirect